Patents
Sitemap › C07 - Organic chemistry › C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium › C07F 9 - Compounds containing elements of the 5th group of the periodic system
Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
12/2003
12/31/2003CA2490043A1 8-(biaryl) quinoline pde4 inhibitors
12/31/2003CA2486958A1 Cationic alkoxyamines and their use in producing nano particles from natural or synthetic clays
12/30/2003US6670474 Epoxide derivatives of allylarylphenols
12/30/2003US6670456 Actinium-225 complexes and conjugates for targeted radiotherapy
12/30/2003US6670432 Metal is bound to a delocalized substituted pi-bonded moiety (cyclopentadiene) to induce a constrained geometry about the metal; ethylene-styrene copolymer
12/30/2003US6670344 Having greater solubility than native combretastatin A-4, and rapidly regenerate combretastatin A-4 under physiological conditions; for use in cancer therapy
12/30/2003US6670341 Phosphocholine moiety covalently conjugated with one or more antiviral agents (e.g. nucleoside analogue, protease inhibitor, etc.) to a lipid backbone
12/30/2003CA2091304C Substituted imidazole derivatives
12/25/2003US20030236433 Synthesis of P-chiral bisphospholane ligands and their transition metal complexes for use as asymmetric hydrogenation catalysts
12/25/2003US20030236301 Liposomal delivery of vitamin E based compounds
12/25/2003US20030236233 Process of making phosphordiamidite compounds
12/25/2003US20030236213 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
12/25/2003US20030236212 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
12/25/2003CA2391427A1 Use of phosphoranes as coupling agents and processes for their preparation
12/24/2003WO2003107010A1 Reagents and procedures for high-specificity labeling
12/24/2003WO2003106469A1 Tumour-inhibiting platinum (ii) oxalate complexes
12/24/2003WO2003106468A1 Process of making phosphordiamidite compounds
12/24/2003WO2003106467A1 Chiral catalyst, process for preparing the same and its use in the oxidative coupling of naphthols
12/24/2003WO2003087298A3 Nucleosides preparation thereof and use as inhibitors of rna viral polymerases
12/24/2003WO2003066548A3 Solvent-free mechanochemical preparation of phosphonium salts, phosphorus ylides, and olefins
12/24/2003WO2003062236A8 2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3d]PYRIMIDIN-7-ONES
12/24/2003WO2003042135A3 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
12/24/2003WO2002092608A3 Use of a composition of an ionic nature as a substrate reagent, a composition constituting a fluorination reagent and a method using same
12/24/2003WO2002034204A8 Calcilytic compounds
12/24/2003CN1463270A Disulfide prodrugs and linkers and stablizers useful therefore
12/24/2003CN1463263A Method to inhibit ethylene responses in plants
12/24/2003CN1462753A Method for synthesizing 4-substituted amido benzyl phosphonium salt
12/24/2003CN1462752A Chemotherapy medication-coupler of gem-bis phosphoric acid and synthetic method as well as usage
12/24/2003CN1131855C 1－取代－1－氨基甲基－环烷衍生物(=加巴喷丁类似物)、其制备及其在治疗神经病方面的用途 L-amino-1-substituted methyl - naphthenic derivative (= gabapentin analogs), their preparation and their use in the treatment of neuropathy
12/24/2003CN1131850C Process to prepare terminal aldehyde
12/23/2003US6667386 Linear, alternating copolymerization of carbon monoxide and alpha-olefins in aqueous media; constantly high average catalyst activity
12/23/2003US6667355 Higher alkylated triaryl phosphate ester flame retardants
12/23/2003US6667340 Inhibitors of phosphatidyl myo-inositol cycle
12/23/2003US6667339 Contraceptive
12/23/2003US6667315 Pyridoxine phosphonate analogues such as, for example, ((2-methyl-3-hydroxy-4-hydroxymethyl-5-pyridyl)alkylphosphonates, and (2-methyl-3-hydroxy-4-hydroxymethyl-5-pyridyl)azaalkylphosphonates)
12/23/2003US6667284 A coverings on a magnetic head for reading and writing on a computer disk drives, audio and video equipment; wear resistance; a compound select from hydrocarbyl-substituted cyclopentanes, cyclopentenes or cyclopentadienes
12/23/2003US6667053 D and L etherlipid stereoisomers and liposomes
12/18/2003WO2003104249A1 Novel linker for nucleotides
12/18/2003WO2003104246A1 Carbacyclic phosphatidic acid derivative
12/18/2003WO2003104245A1 Multimer forms of mono- and bis-acylphosphine oxides
12/18/2003WO2003104243A1 Chemical synthesis of reagents for peptide coupling
12/18/2003WO2003104223A1 Pyrazole-derivatives as p38 kinase inhibitors
12/18/2003WO2003104184A1 Methods for synthesis of acyloxyalkyl derivatives of gaba analogs
12/18/2003WO2003103816A2 An aqueous dispersion containing pyrogenically prepared metal oxide particles and dispersants
12/18/2003WO2003103686A1 Thrombopoietin mimetics
12/18/2003WO2003087130A3 Process for manufacturing purified phosphorodiamidite
12/18/2003WO2003078444A3 Bisphosphite ligands for carbonylation processes
12/18/2003WO2003068719A3 Production of oxygenated products
12/18/2003WO2003042224A3 Preparation of derivatives of a group 5a element
12/18/2003WO2002079271A3 Acid macromonomers and their method of preparation
12/18/2003WO2002062398A3 Radioactively labelled conjugates of phosphonates
12/18/2003US20030232991 For use in asymmetric hydrogenation, hydride transfer, hydrosilylation, hydroboration, hydrovinylation, hydroformylation, hydrocarboxylation, isomerization, allylic alkylation, cyclopropanation, Diels-Alder reaction, etc.
12/18/2003US20030232979 Nucleic acid labeling compounds
12/18/2003US20030232788 Inhibitors of interleukin-1 beta converting enzyme and related proteases
12/18/2003US20030229949 Hair dyes; fast coloration of keratin fibers
12/18/2003CA2489246A1 Multimer forms of mono- and bis-acylphosphine oxides
12/18/2003CA2489186A1 Chemical synthesis of reagents for peptide coupling
12/18/2003CA2488402A1 Pyrazole-derivatives as p38 kinase inhibitors
12/17/2003EP1371656A1 Mixtures of a phosphonite and other components
12/17/2003EP1371655A1 Novel diphosphine compound, production intermediate thereof, transition metal complex containing the compound as ligand and asymmetric hydrogenation catalyst containing the complex
12/17/2003EP1370565A2 Method of producing 1-hydroxy-1,1-diphosphonic acid compounds
12/17/2003EP1370564A2 Resveratrol-phospholipids complexes
12/17/2003EP1370527A1 Indolone derivatives having vascular-damaging activity
12/17/2003EP1370301A2 Actinium-225 complexes and conjugates for targeted radiotherapy
12/17/2003EP1370255A2 Cdc25 phosphatase inhibitors
12/17/2003EP1259519B1 Method for preparing sterically hindered phosphoramidates
12/17/2003EP1218380B1 Bicyclic imidazo-3-yl-amine derivatives which are substituted on the sixth ring
12/17/2003EP1157031B1 Oligomers substituted by phosphonic acid ester, phosphonic acid or carbaborane functions and the corresponding pna monomers
12/17/2003EP1027358B1 Anhydrous mononuclear tris(beta-diketonate) bismuth compositions for deposition of bismuth-containing films, and method of making the same
12/17/2003EP1003607B1 Supported diols
12/17/2003CN1462275A Phosphonocephem compound
12/17/2003CN1131231C Cross-linked phenoxyphosphazene compound, process for preparing the same, flame retardant, flame-retardant resin composition and molded flame-retardant resin
12/16/2003US6664427 Process for preparing aldehyde compounds
12/16/2003US6664365 Process for producing poly(alkylene oxide) in the presence of a phosphazenium salt or compound
12/16/2003US6664245 Adhesive compositions for hard tissues
12/16/2003US6664058 A nucleotide, e.g., 6-(beta-D-2-Deoxyribofuranosyl)-5-hydro-methyl-8H-pyrimido(4,5 -c)(1,2)pyridazin-7-one-5'-triphosphate, incorporated into a polynuceotide or an oligomucleotide; viricides; labels
12/11/2003WO2003102202A2 Process for preparing vinylaromatic compounds
12/11/2003WO2003102004A1 Amorphous solid modification of bis(2,4-dicumylphenyl) pentaerythritol diphosphite
12/11/2003WO2003102003A1 Fluorinated phosphonic acids
12/11/2003WO2003102002A1 Silicon polyazides and a method for their production
12/11/2003WO2003102000A1 Shaped bodies containing metal-organic frameworks
12/11/2003WO2003101978A1 Phenyl-thiophene type vitamin d receptor modulators
12/11/2003WO2003080630A3 Phosphate transport inhibitors
12/11/2003WO2002087465A3 Compositions and methods of double-targeting virus infections and cancer cells
12/11/2003WO2002083071A3 Heterocyclic analgesic compounds and methods of use thereof
12/11/2003WO2002048165A8 Antiviral agents for treatment of flaviviridae infections
12/11/2003US20030229246 Liquid phase catalytic oxidation
12/11/2003US20030229245 Catalytic oxidation of phosphonomethyliminodiacetic acid
12/11/2003US20030229240 Process for preparing tertiary phosphines
12/11/2003US20030229225 Novel phosphonic acid based prodrugs of PMEA and its analogues
12/11/2003US20030229219 Preparation of phosphorothioate oligomers
12/11/2003US20030229113 Keratinocyte growth inhibitors and hydroxamic acid derivatives
12/11/2003US20030229095 Sexual disorders
12/11/2003US20030229089 Cyclic compounds
12/11/2003US20030229054 Novel amines as pharmaceutical agents
12/11/2003US20030229051 Anticancer agents; restenosis; atherosclerosis; skin disorders
12/11/2003US20030228977 Novel diphosphine compound, production intermediate thereof, transition metal complex containing the compound as ligand and asymmetric hydrogenation catalyst containing the complex
12/11/2003US20030228629 Polymer-supported phosphorus ligands for catalysts
12/11/2003US20030228469 Fluorinated phosphonic acids
12/11/2003DE10235574C1 Use of dialkyl alkylamido thiophosphate as collector in flotation of sulfide ore, especially with non-ferrous ore, e.g. copper, nickel, zinc, lead or molybdenum sulfide ore
1 ... 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 ... 554